Effectiveness of Monovalent mRNA Vaccines Against COVID-19–Associated Hospitalization Among Immunocompetent Adults During BA.1/BA.2 and BA.4/BA.5 Predominant Periods of SARS-CoV-2 Omicron Varian
by from Morbidity and Mortality Weekly Report (MMWR) on (#64YNG)
This report describes three-dose monovalent COVID-19 vaccine effectiveness against COVID-19 hospitalization during Omicron predominance.